Category - Executive Moves

Executive Moves

Zenabis names Shai Altman as president and CEO

Zenabis Global (TSX:ZENA) appointed Shai Altman as president and CEO, effective September 1. Mr. Altman will replace interim CEO, Kevin Coft, who will return to his role as Zenabis’ chief facilities officer. Mr. Altman...

July 31, 2020

Executive Moves

Canaccord boosts healthcare investment banking team

Canaccord Genuity named Thomas O’Connor as managing director, co-head of U.S. healthcare investment banking, with long-time partners, Matt Steere and Eugene Rozelman, joining Mr. O’Connor as fellow co-heads of the U.S...

July 23, 2020

Executive Moves

Rhythm Pharma appoints Dr. David Meeker as CEO

Rhythm Pharmaceuticals (NASDAQ:RYTM) appointed its chairman, Dr. David Meeker as CEO, effective immediately. Dr. Meeker replaces interim president and CEO, Hunter Smith, who will continue in his role as CFO. Dr. Meeker...

July 20, 2020

Executive Moves

Sun BioPharma names Jennifer Simpson as president and CEO

Sun BioPharma (OTCQB:SNBP) appointed Jennifer Simpson as president and CEO, replacing co-founder Michael Cullen, who will continue to serve as the company’s executive chairman. Dr. Simpson has more than 25 years of...

July 17, 2020

Executive Moves

Neuronetics names Keith Sullivan as president and CEO

Neuronetics (NASDQ:STIM) appointed Keith Sullivan as president and CEO, effective immediately. Christopher Thatcher, the company’s previous president and CEO, resigned in March 2020. Mr. Sullivan has more than three...

July 14, 2020

Executive Moves

Elemer Piros rejoins Roth healthcare research team

Elemer Piros has rejoined the healthcare research team at Roth Capital Partners as managing director, senior research analyst covering biotechnology. His research coverage is expected to include small- and mid-cap...

July 9, 2020

Executive Moves

Strongbridge Biopharma names John Johnson as CEO

Strongbridge Biopharma (NASDAQ:SBBP) appointed its executive chairman, John Johnson, as the company’s CEO, effective immediately. Mr. Johnson served as Strongbridge’s chairman since March 2015. In November 2019, he took...

July 7, 2020

Executive Moves

Chimerix appoints Allen Melemed as CMO

Chimerix (NASDAQ:CMRX) appointed Dr. Allen Melemed as its CMO. Dr. Melemed was most recently a distinguished medical fellow and senior director of North American regulatory affairs oncology at Eli Lilly (NYSE:LLY). He...

June 22, 2020

Executive Moves

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

NeuroOne Medical Technologies (OTCQB:NMTC) appointed neural engineer, Camilo Andres Diaz-Botia, as director of electrode development. Dr. Diaz-Botia previously led the microfabrication process engineering team at...

June 17, 2020

Executive Moves

Hepion names drug development expert, Dr. Peter Wijngaard, to its board

Hepion Pharmaceuticals (NASDAQ:HEPA) appointed industry veteran, Dr. Peter Wijngaard, to its board of directors. “Dr. Wijngaard provided invaluable guidance to Hepion’s management team during our earlier work on...

June 10, 2020

Category - Executive Moves

Zenabis names Shai Altman as president and CEO

Canaccord boosts healthcare investment banking team

Rhythm Pharma appoints Dr. David Meeker as CEO

Sun BioPharma names Jennifer Simpson as president and CEO

Neuronetics names Keith Sullivan as president and CEO

Elemer Piros rejoins Roth healthcare research team

Strongbridge Biopharma names John Johnson as CEO

Chimerix appoints Allen Melemed as CMO

NeuroOne appoints neural engineering expert, Camilo Andres Diaz-Botia, as director of electrode development

Hepion names drug development expert, Dr. Peter Wijngaard, to its board

Follow Us

General

More

Sign up for the BioTuesdays weekly newsletter